Michael Jon Chisamore
8PUBLICATIONS
134CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.Jhanelle E Gray, Joel W Neal, Jyoti D Patel
|Dec 22, 2025
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.Danny Rischin, Aaron R Hansen, Ezra E W Cohen
|Jul 25, 2025
Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Advanced Melanoma.Antoni Ribas, Mohammed M Milhem, Christopher J Hoimes
|May 01, 2025
Safety and Tolerability of Lete-cel in NSCLC-Reply.Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann
|Feb 05, 2025
The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial.Matthew Stephen Block, James Hugo Armstrong Clubb, Johanna Mäenpää
|Nov 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer.Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann
Pageof 2
Frequent Collaborators
3 joint publications
Joel W Neal
2 joint publications
Mehmet Altan
2 joint publications
Martin J Edelman
2 joint publications
Gilberto Lopes
2 joint publications
Emiliano Calvo
2 joint publications
Marc Ballas
2 joint publications
Liza C Villaruz
2 joint publications
T Jeroen N Hiltermann
2 joint publications
Danny Rischin
2 joint publications
Catherine Ellis
